Form D · Biotechnology
Lion Biotechnologies, Inc.
New York, NY · CIK 0001425205
Offering snapshot reported Jun 15, 2016 · SEC filing
- Reported sold
- $100M Offering amount: $100M
- Investors reported
- 24 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 2, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 15, 2016 | Initial | $100,000,000 | No comparison | 24 | SEC filing |
| Nov 15, 2013 | Initial | $23,290,600 | No comparison | 117 | SEC filing |
| Jun 6, 2013 | Initial | $1,350,000 | No comparison | 30 | SEC filing |
| Aug 9, 2011 | Initial | $5,000,000 | No comparison | 5 | SEC filing |
| May 3, 2011 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Jan 21, 2011 | Initial | $640,000 | No comparison | 9 | SEC filing |
| Nov 8, 2010 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Oct 1, 2010 | Initial | $500,000 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $4M
- Finders' fees
- $0
- Form D file number
- 021-265134
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Jefferies LLC | 2347 | |
| Piper Jaffray & Co. | 665 |
Source: Form D, filed Jun 15, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ibrahim Abotaleb | Promoter |
| Mark J. Ahn | Director |
| Dr. William Andrews | Director |
| Robert T. Brooke | Director, Executive |
| Anthony Cataldo | Director, Executive |
| Dr. L. Stephen Coles | Director |
| Maria Fardis | Director, Executive |
| Steven A. Fischkoff | Executive |
| Michael Handelman | Executive |
| Molly C. Henderson | Executive |
| Sanford J, Hillsberg | Director |
| Paul Kessler | Director |
| Gerald Lewis | Promoter |
| Michael T. Lotze | Executive |
| Ryan Maynard | Director |
| Richard Mckilligan | Director, Executive |
| Richard Mc Killigan | Director, Executive |
| Merrill Mc Peak | Director |
| Wayne Rothbaum | Director |
| Martin Schroeder | Director |
| Manish Singh | Director, Executive |
| Jay Venkatesan | Director |
| David Voyticky | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
112 West 34 Th Street 17 Th Floor
New York, NY, 10120
New York, NY, 10120